Cognitive Decline

Men who experience behavioral changes, such as apathy or hallucinations, are at a faster risk for cognitive decline compared with women, findings published in the Journal of Alzheimer’s Disease showed.

PHILADELPHIA — Diabetes independently increases risk for cognitive decline, yet data from several large trials suggest GLP-1 receptor agonists hold significant promise to mitigate risk for dementia-related events, according to a speaker.

Cumulative cardiovascular risk is a significant factor in determining the risk for cognitive decline and dementia, according to a study published in Neurology.

Positive airway pressure therapy may delay cognitive decline in adults with obstructive sleep apnea, but more research is needed, according to a systematic review published in Neurology.

BOSTON — “Geriatric problems” can lead to adverse events among older patients with chronic kidney disease, but these can be identified and solved with assessments specific to this group, according to a speaker here.

Women who reported at least 2 months of antibiotic exposure in midlife experienced small decreases in cognition, which may be due to changes in the gut microbiome, data published in PLoS One showed.

An increased risk for cognitive decline was associated with adults aged 60 years and older, following severe cases of COVID-19, in Wuhan, China, experts reported in JAMA Neurology.

A recent review of electronic health records showed that 4% of adults who were hospitalized with COVID-19 in the beginning of the pandemic were newly diagnosed with diabetes.

At 10 years, higher baseline levels of systemic inflammatory markers, including plasma interleukin-6 and fibrinogen, were associated with greater cognitive decline for adults with type 2 diabetes, according to data.

Certain antihypertensive medications may help prevent cognitive decline, according to results of a cohort study published in JAMA Network Open.